Zobrazeno 1 - 10
of 7 827
pro vyhledávání: '"ABIRATERONE acetate"'
Autor:
Fukuokaya W; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan. wfukuokaya@gmail.com., Mori K; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Akazawa K; Department of Medical Informatics, Niigata University Medical and Dental Hospital; 1-754 Asahimachi-dori, Chuo-ku, Niigata, Japan., Shimomura T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine; 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Publikováno v:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep; Vol. 27 (3), pp. 444-450. Date of Electronic Publication: 2023 Jul 18.
Autor:
Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France. Electronic address: g.roubaud@bordeaux.unicancer.fr., Attard G; University College London Cancer Institute, London, UK., Boegemann M; Department of Urology, Muenster University Hospital, Muenster, Germany; Westgerman Cancer Center, Münster, Germany., Olmos D; Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain., Trevisan M; Janssen EMEA, Geneva, Switzerland., Antoni L; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Pascoe K; Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Capone C; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Van Sanden S; Janssen Pharmaceutica NV, Beerse, Antwerp, Belgium., Hashim M; Janssen Vaccines & Prevention B.V., Leiden, the Netherlands., Palmer S; Centre for Health Economics, University of York, York, UK., Chi K; BC Cancer and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 209, pp. 114183. Date of Electronic Publication: 2024 Jun 17.
Autor:
De Santis M; Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Urology, Medical University Vienna, Vienna, Austria., Breijo SM; A Coruña University Hospital, C/As Xubias de Arriba nº 86, 15006, A Coruña, Spain.; Department of Urology, Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidad de A Coruña (UDC), 15006, A Coruña, Spain., Robinson P; Janssen-Cilag Limited, 50-100 Holmers Farm Way, High Wycombe, HP12 4EG, UK., Capone C; Janssen-Cilag, 1 Rue Camille Desmoulins, 92130, Issy Les Moulineaux, France. ccapone3@ITS.JNJ.com., Pascoe K; Janssen-Cilag Limited, 50-100 Holmers Farm Way, High Wycombe, HP12 4EG, UK., Van Sanden S; Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse, Belgium., Hashim M; Janssen Vaccines & Prevention BV, Archimedesweg 4-6, 2333 CN, Leiden, The Netherlands., Trevisan M; Janssen-Cilag AG, Gubelstrasse 34, 6300, Zug, Switzerland., Daly C; Cytel Inc., 1 University Avenue, 3rd Floor, Toronto, ON, M5J 2P1, Canada., Reitsma F; Cytel Inc., Weena 316-318, 3012 NJ, Rotterdam, The Netherlands., van Beekhuizen S; Cytel Inc., Weena 316-318, 3012 NJ, Rotterdam, The Netherlands., Ruan H; Cytel Inc., 1 University Avenue, 3rd Floor, Toronto, ON, M5J 2P1, Canada., Heeg B; Cytel Inc., Weena 316-318, 3012 NJ, Rotterdam, The Netherlands., Verzoni E; SSD Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3039-3058. Date of Electronic Publication: 2024 Jul 03.
Autor:
Aparicio AM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Tidwell RSS; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas., Yadav SS; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas., Chen JS; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang M; Department of Anatomical Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Liu J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Guo S; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas., Pilié PG; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Yu Y; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas., Song X; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas., Vundavilli H; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Jindal S; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas., Zhu K; Department of Anatomical Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Viscuse PV; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Lebenthal JM; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Hahn AW; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Soundararajan R; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Corn PG; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Zurita-Saavedra A; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Subudhi SK; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas., Wang W; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Huff C; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas., Troncoso P; Department of Anatomical Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas., Allison JP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas., Sharma P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas., Logothetis CJ; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 01; Vol. 30 (13), pp. 2751-2763.
Autor:
Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit - ISPRO, Florence, Italy., Lee-Ying R; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Patrikidou A; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zanardi E; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Rossetti S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., Davidsohn M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Damassi A; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Oliveira TM; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Malgeri A; Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy., Modesti M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Ravi P; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Pignata S; IRCCS Istituto Nazionale dei Tumori Fondazione G. Pascale, Naples, Italy., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Department of Oncology, University of Calgary Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102185. Date of Electronic Publication: 2024 Aug 09.
Autor:
Sudhakaran G; Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Tamil Nadu, India. Electronic address: gokuls.smc@saveetha.com.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102152. Date of Electronic Publication: 2024 Jul 03.
Autor:
Suzuki K; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. Electronic address: pikataro1012@gmail.com., Shiraishi Y; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Furukawa J; Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Okamura Y; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Bando Y; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Hara T; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Okada K; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Terakawa T; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Hyodo Y; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Chiba K; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Teishima J; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Nakano Y; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Miyake H; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102140. Date of Electronic Publication: 2024 Jun 14.
Autor:
Lam B; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Rodgers JE; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA., Muluneh B; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Proco D; GlaxoSmithKline, Research Triangle Park, Durham, North Carolina, USA., Whang YE; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Morgan KP; University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.
Publikováno v:
The Annals of pharmacotherapy [Ann Pharmacother] 2024 Oct; Vol. 58 (10), pp. 994-1002. Date of Electronic Publication: 2024 Feb 12.
Autor:
Chamorey E; Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Pujalte-Martin M; Medical Oncology Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Ferrero JM; Medical Oncology Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Mahammedi H; Medical Oncology Department, Centre Jean Perrin, 63000 Clermond Ferrand, France., Gravis G; Medical Oncology Department, Institut Paoli Calmette, 13009 Marseille, France., Roubaud G; Department of Medical Oncology, Institut Bergonié, 33076 Bordeaux, France., Beuzeboc P; Medical Oncology Department, Institut Curie, 75005 Paris, France., Largillier R; Medical Oncology Department, Centre Azuréen de Cancérologie, 06250 Mougins, France., Borchiellini D; Medical Oncology Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France.; Clinical Research Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Linassier C; Medical Oncology Department, Centre Hospitalier Régional Universitaire, 37000 Tours, France., Bouges H; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06189 Nice, France., Etienne-Grimaldi MC; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06189 Nice, France., Schiappa R; Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Gal J; Epidemiology and Biostatistics Department, Centre Antoine Lacassagne, University Côte d'Azur, 06000 Nice, France., Milano G; Oncopharmacology Unit, Centre Antoine Lacassagne, University Côte d'Azur, 06189 Nice, France.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 May 31; Vol. 25 (11). Date of Electronic Publication: 2024 May 31.
Autor:
Yu EY; Division of Hematology and Oncology, Fred Hutchinson Cancer Center and University of Washington, Seattle, WA, USA. Electronic address: evanyu@u.washington.edu., Berry WR; Duke Cancer Center Cary, Cary, NC, USA., Gurney H; Department of Clinical Medicine, Macquarie University, Sydney, Australia., Retz M; University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany., Conter HJ; University of Western Ontario, Brampton, Canada., Laguerre B; Center Eugène Marquis, Rennes, France., Fong PCC; Aukland City Hospital and the University of Aukland., Ferrario C; Jewish General Hospital, Montreal, Canada., Todenhöfer T; Studienpraxis Urologie, Nürtingen, Germany., Gravis G; Institut Paoli-Calmettes, Marseille, France., Piulats JM; Catalan Institute of Oncology, Barcelona, Spain., Emmenegger U; Division of Medical Oncology, Odette Cancer Centre, Toronto, Canada., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Romano E; Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France., Mourey L; Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Li XT; MSD China, Beijing, China., Poehlein CH; Merck & Co., Inc., Rahway, NJ, USA., Schloss C; Merck & Co., Inc., Rahway, NJ, USA., Appleman LJ; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., de Bono JS; The Institute of Cancer Research, The Royal Marsden Hospital, London, UK.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 509-518. Date of Electronic Publication: 2023 Nov 07.